IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and …
What to know about IDXX
IDEXX Laboratories, Inc. is a large Healthcare company with a mixed financial profile. It scores well on profitability and health, but valuation is worth keeping an eye on.
Should you consider IDXX?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
IDEXX Laboratories, Inc. is a large-cap Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (29 of 59).
-
The business is both profitable and financially healthy — it keeps a good portion of what it earns and carries its debt comfortably.
-
The stock trades at a premium — investors are paying more per dollar of earnings than most S&P 500 companies. That's fine if strong growth justifies it, but leaves little room for disappointment.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
The stock is more volatile than most S&P 500 names — it can swing sharply in both directions. This suits investors comfortable with bigger short-term moves.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Healthcare sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how IDXX compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 41.39 | Below avg |
| Forward P/E | 34.03 | Below avg |
| PEG Ratio | 3.67 | Below avg |
| Price to Sales | 9.97 | Below avg |
| Price to Book | 28.62 | Below avg |
| EV/EBITDA | 29.82 | Below avg |
| Earnings Yield | 2.42% | Below avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 62.05% | Top 25% |
| Operating Margin | 31.78% | Top 25% |
| Net Profit Margin | 24.63% | Top 25% |
| Return on Equity | 72.91% | Top 25% |
| Return on Invested Capital | 26.46% | Top 25% |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 14.30% | Above avg |
| Revenue Growth (3Y CAGR) | 8.52% | Above avg |
| EPS Growth (YoY) | 17.20% | Above avg |
| Free Cash Flow Growth | 30.76% | Top 25% |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.12 | Average |
| Debt to Equity | 0.71 | Above avg |
| Interest Coverage | 35.08 | Top 25% |
| Altman Z-Score | 20.63 | Top 25% |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | 0.00% | Top 25% |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 2.41% | Average |
| OCF to Sales | 27.22% | Above avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 1.54 | Below avg |
| Volatility (30-Day) | 33.44% | Average |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.16% | Above avg |
| Avg. Analyst Rating | 2.13 | Average |
| Target Upside % | 26.16% | Above avg |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 44.34B | Above avg |
How does IDXX compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to IDXX — based on their financial profile.